AJ

Active Director Director DIN 08836425
DIN 08836425 First appointment Aug 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Anna Jain

Data last updated:

Anna Jain is a Director at Aqutrus Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Aqutrus Pharmaceuticals Private Limited reported revenue of ₹6.7 Lakh (FY 2021).

DIN 08836425
Primary Designation Director
Industry Chemicals
First Appointment 17 Aug 2020
Oldest Company Age 6 yrs
Largest company Aqutrus Pharmaceuticals Private Limited · ₹6.7 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Aug 20202020₹6.7 Lakh (FY 2021)Active

Board colleagues of Anna Jain

NameDINCompanyDesignation
Ankit Jain Baj08836426Aqutrus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aqutrus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anna Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anna Jain

Anna Jain currently holds 1 directorship: Aqutrus Pharmaceuticals Private Limited (Director, since 17 Aug 2020, revenue ₹6.7 Lakh (FY 2021)).

Anna Jain was first appointed on 17 Aug 2020 as Director at Aqutrus Pharmaceuticals Private Limited.

The current boards of Anna Jain's companies include Ankit Jain Baj (Aqutrus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available